Evidence map›Paper›PMID 24204966›Full record

ArticlePloS one2013

The CHC22 clathrin-GLUT4 transport pathway contributes to skeletal muscle regeneration.

Sachiko Hoshino, Kazuho Sakamoto, Stéphane Vassilopoulos, Stéphane M Camus, Christine A Griffin, Christopher Esk, Jorge A Torres, Norio Ohkoshi, Akiko Ishii, Akira Tamaoka and 5 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Skeletal Muscle Regeneration in Cardiotoxin-Induced Muscle Injury Models.International journal of molecular sciences · 2022
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Sachiko HoshinoThe G.W. Hooper Foundation, Departments of Bioengineering and Therapeutic Sciences, Pharmaceutical Chemistry, and Microbiology and Immunology, University of California San Francisco, San Francisco, California, United States of America ; Department of Neurology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Kazuho Sakamoto
Stéphane Vassilopoulos
Stéphane M Camus
Christine A Griffin
Christopher Esk
Jorge A Torres
Norio Ohkoshi
Akiko Ishii
Akira Tamaoka
Birgit H Funke
Raju Kucherlapati
Marta Margeta
Thomas A Rando
Frances M Brodsky
San Francisco Foundation · USUniversity of California, San Francisco · USStanford University · USUniversity of Tsukuba · JPFukushima Medical University · JPHarvard University · USTsukuba University of Technology · JP

Funding

Wnt signaling in muscle stem cell agingP01AG036695 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MARGARET A. GOODELL · 2011 to 2026
$29.3M
Research BaseP30DK063720 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRUMMEL, MATTHEW F · 2003 to 2019
$21.8M
THE MOLECULAR MECHANISM OF CLATHRIN ASSEMBLYR01GM038093 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BRODSKY, FRANCES M. · 1988 to 2014
$5.0M
Notch Signaling and Satellite Cell ActivationR37AG023806 · NIA · STANFORD UNIVERSITY · PI RANDO, THOMAS A. · 2010 to 2019
$2.9M
Molecular Regulation of Myogenic DifferentiationR01AR056849 · NIAMS · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI RANDO, THOMAS A. · 2009 to 2013
$1.5M
The Function and Regulation of Pax3 in Muscle Stem CellsR01AR062185 · NIAMS · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI RANDO, THOMAS A. · 2011 to 2015
$1.5M
Comparative Genetics of the DiGeorge Syndrome Gene TBX1R01HD047863 · NICHD · BRIGHAM AND WOMEN'S HOSPITAL · PI KUCHERLAPATI, RAJU S. · 2005 to 2009
$1.5M
Biochemistry and Cell Biology of CHC22 ClathrinR01DK095663 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BRODSKY, FRANCES M. · 2013 to 2016
$1.4M
Notch Signaling and Satellite Cell ActivationR01AG023806 · NIA · STANFORD UNIVERSITY · PI RANDO, THOMAS A. · 2005 to 2009
$1.2M
CHC22 CLATHRIN FUNCTION IN HUMAN GLUCOSE METABOLISMR56DK083589 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BRODSKY, FRANCES M. · 2009 to 2009
$386k
NIAMS NIH HHS R01 AR056849NIAMS NIH HHS R01 AR062185NIA NIH HHS P01 AG036695NIA NIH HHS R01 AG023806NIA NIH HHS R37 AG023806NICHD NIH HHS R01 HD047863NICHD NIH HHS R01-HD47863NIDDK NIH HHS P30 DK063720NIDDK NIH HHS P30-DK063720NIDDK NIH HHS R01 DK095663NIDDK NIH HHS R01-DK095663NIDDK NIH HHS R56 DK083589NIDDK NIH HHS R56-DK083589NIGMS NIH HHS R01 GM038093NIGMS NIH HHS R01-GM038093
6 · The paper itself

Abstract

Mobilization of the GLUT4 glucose transporter from intracellular storage vesicles provides a mechanism for insulin-responsive glucose import into skeletal muscle. In humans, clathrin isoform CHC22 participates in formation of the GLUT4 storage compartment in skeletal muscle and fat. CHC22 function is limited to retrograde endosomal sorting and is restricted in its tissue expression and species distribution compared to the conserved CHC17 isoform that mediates endocytosis and several other membrane traffic pathways. Previously, we noted that CHC22 was expressed at elevated levels in regenerating rat muscle. Here we investigate whether the GLUT4 pathway in which CHC22 participates could play a role in muscle regeneration in humans and we test this possibility using CHC22-transgenic mice, which do not normally express CHC22. We observed that GLUT4 expression is elevated in parallel with that of CHC22 in regenerating skeletal muscle fibers from patients with inflammatory and other myopathies. Regenerating human myofibers displayed concurrent increases in expression of VAMP2, another regulator of GLUT4 transport. Regenerating fibers from wild-type mouse skeletal muscle injected with cardiotoxin also showed increased levels of GLUT4 and VAMP2. We previously demonstrated that transgenic mice expressing CHC22 in their muscle over-sequester GLUT4 and VAMP2 and have defective GLUT4 trafficking leading to diabetic symptoms. In this study, we find that muscle regeneration rates in CHC22 mice were delayed compared to wild-type mice, and myoblasts isolated from these mice did not proliferate in response to glucose. Additionally, CHC22-expressing mouse muscle displayed a fiber type switch from oxidative to glycolytic, similar to that observed in type 2 diabetic patients. These observations implicate the pathway for GLUT4 transport in regeneration of both human and mouse skeletal muscle, and demonstrate a role for this pathway in maintenance of muscle fiber type. Extrapolating these findings, CHC22 and GLUT4 can be considered markers of muscle regeneration in humans.

Indexed as

AnimalsCase-Control StudiesCell DifferentiationCells, CulturedClathrinClathrin Heavy ChainsGlucoseGlucose Transporter Type 4HumansImmunoblottingMiceMice, TransgenicMuscle Fibers, SkeletalMuscle, SkeletalMuscular DiseasesMyoblastsClathrinClathrin Heavy ChainsCLTCL1 protein, humanGlucoseGlucose Transporter Type 4

Identifiers

PMID24204966
PMCPMC3813726
OpenAlexW2145164437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.